The Securities and Exchange Commission has not necessarily reviewed the information in this filing and has not determined if it is accurate and complete. | |||||||||||||||||||||
UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 13F FORM 13F INFORMATION TABLE |
|
COLUMN 1 | COLUMN 2 | COLUMN 3 | COLUMN 4 | COLUMN 5 | COLUMN 6 | COLUMN 7 | COLUMN 8 | ||||
VALUE | SHRS OR | SH/ | PUT/ | INVESTMENT | OTHER | VOTING AUTHORITY | |||||
NAME OF ISSUER | TITLE OF CLASS | CUSIP | (x$1000) | PRN AMT | PRN | CALL | DISCRETION | MANAGER | SOLE | SHARED | NONE |
ACCELERATE DIAGNOSTICS INC | COM | 00430H102 | 80,745 | 4,348,140 | SH | SOLE | 4,348,140 | 0 | 0 | ||
ACCELERATE DIAGNOSTICS INC | COM | 00430H102 | 687 | 900,100 | SH | Call | SOLE | 900,100 | 0 | 0 | |
AGENUS INC | COM NEW | 00847G705 | 4,665 | 1,808,296 | SH | SOLE | 1,808,296 | 0 | 0 | ||
AMARIN CORP PLC | SPONS ADR NEW | 023111206 | 76,349 | 5,036,220 | SH | SOLE | 5,036,220 | 0 | 0 | ||
AMARIN CORP PLC | SPONS ADR NEW | 023111206 | 108 | 120,000 | SH | Call | SOLE | 120,000 | 0 | 0 | |
ANTARES PHARMA INC | COM | 036642106 | 964 | 288,237 | SH | SOLE | 288,237 | 0 | 0 | ||
BIOGEN INC | COM | 09062X103 | 1,483 | 6,368 | SH | SOLE | 6,368 | 0 | 0 | ||
BIOHAVEN PHARMACTL HLDG CO L | COM | G11196105 | 966 | 596,000 | SH | Call | SOLE | 596,000 | 0 | 0 | |
BIOHAVEN PHARMACTL HLDG CO L | COM | G11196105 | 1,807 | 126,400 | SH | Put | SOLE | 126,400 | 0 | 0 | |
BIOHAVEN PHARMACTL HLDG CO L | COM | G11196105 | 74,256 | 1,779,875 | SH | SOLE | 1,779,875 | 0 | 0 | ||
BIOLASE INC | COM NEW | 090911207 | 4,863 | 5,173,250 | SH | SOLE | 5,173,250 | 0 | 0 | ||
CONTRAFECT CORP | COM | 212326102 | 1,573 | 4,392,713 | SH | SOLE | 4,392,713 | 0 | 0 | ||
DERMIRA INC | COM | 24983L104 | 11,718 | 1,833,785 | SH | SOLE | 1,833,785 | 0 | 0 | ||
MOTUS GI HLDGS INC | COM | 62014P108 | 7,537 | 3,806,666 | SH | SOLE | 3,806,666 | 0 | 0 | ||
OPKO HEALTH INC | COM | 68375N103 | 12,144 | 5,810,376 | SH | SOLE | 5,810,376 | 0 | 0 | ||
PACIFIC BIOSCIENCES CALIF IN | COM | 69404D108 | 5,731 | 1,110,666 | SH | SOLE | 1,110,666 | 0 | 0 | ||
QUIDEL CORP | COM | 74838J101 | 109,477 | 1,784,464 | SH | SOLE | 1,784,464 | 0 | 0 | ||
QUIDEL CORP | COM | 74838J101 | 490 | 73,900 | SH | Call | SOLE | 73,900 | 0 | 0 | |
SOLENO THERAPEUTICS INC | COM NEW | 834203200 | 5,806 | 3,870,627 | SH | SOLE | 3,870,627 | 0 | 0 | ||
SPDR SERIES TRUST | S&P BIOTECH | 78464A870 | 51 | 250,000 | SH | Call | SOLE | 250,000 | 0 | 0 | |
VERMILLION INC | COM NEW | 92407M206 | 5,134 | 9,825,289 | SH | SOLE | 9,825,289 | 0 | 0 |